Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Breast Neoplasms 2046Triple Negative Breast Neoplasms 208Neoplasm Metastasis 133Neoplasms 119Carcinoma, Non-Small-Cell Lung 96Breast Neoplasms, Male 95Ovarian Neoplasms 89Colorectal Neoplasms 70Lung Neoplasms 67Carcinoma, Intraductal, Noninfiltrating 63Melanoma 57Prostatic Neoplasms 55Pancreatic Neoplasms 47Breast Carcinoma In Situ 42Stomach Neoplasms 38Colonic Neoplasms 37Brain Neoplasms 36Carcinoma, Renal Cell 35Inflammatory Breast Neoplasms 33Head and Neck Neoplasms 32Urinary Bladder Neoplasms 29Pain 29Small Cell Lung Carcinoma 27Squamous Cell Carcinoma of Head and Neck 26Endometrial Neoplasms 25Sarcoma 23Fatigue 23Uterine Cervical Neoplasms 21Esophageal Neoplasms 21Multiple Myeloma 18

Interventions

Tobacco Use Cessation Devices 1Radiotherapy 1Celecoxib 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Hand-Foot Syndrome × Breast × Clear all
NCT00751101 2020-10-05

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

University of California, San Francisco

Phase 2 Terminated
24 enrolled 12 charts
Breast

Breast Neoplasms, Hand-Foot Syndrome

NCT00305643 2015-12-24

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

M.D. Anderson Cancer Center

Phase 3 Terminated
11 enrolled 7 charts
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pain, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡